RxDoctor Payments Data

F Alice Bishopric, MD

Obstetrics & Gynecology · Hickory, NCNPI 1225024532

Payments from drug & device makers

$3,125in general payments, 2019–2025

Across 138 payments — averaging $22.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$745
  • Mayne Pharma Commercial LLC$365
  • Astellas Pharma US Inc$317
  • Pfizer$313
  • AMAG Pharmaceuticals, Inc.$197
  • Therapeuticsmd, Inc.$150
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,94394%
  • Education$1645%
  • Gifts$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,125 in reported general payments places this provider in the 80th percentile of 1,344 obstetrics & gynecology providers in North Carolina.

See all obstetrics & gynecology providers in North Carolina

Medicare billing

Part B allowed, 2024
$10,886
Medicare patients
99
Services billed
150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated18$8,084
MyrbetriqMirabegron14$7,526
ImvexxyEstradiol25$6,504
Estradiol70$6,375
Solifenacin Succinate55$3,709
YuvafemEstradiol22$3,292
Estradiol (Twice Weekly)Estradiol11$1,658
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet15$1,054
Norethindron-Ethinyl EstradiolNorethindrone Ac/Eth Estradiol12$790
Ibandronate Sodium22$623
ProgesteroneProgesterone, Micronized22$203
Valsartan14$195
Venlafaxine Hcl ErVenlafaxine Hcl14$195
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst15$171
Escitalopram Oxalate12$138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$313$8,08418 claims
Astellas Pharma US IncMyrbetriq$317$7,52614 claims
Therapeuticsmd, Inc.Imvexxy$150$6,50425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,344 obstetrics & gynecology providers in North Carolina.

Other obstetrics & gynecology in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →